Document Detail


Cancer research network: using integrated healthcare delivery systems as platforms for cancer survivorship research.
MedLine Citation:
PMID:  23239136     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
INTRODUCTION: Much progress has been made in cancer survivorship research, but there are still many unanswered questions that can and need to be addressed by collaborative research consortia. METHODS: Since 1999, the National Cancer Institute-funded HMO Cancer Research Network (CRN) has engaged in a wide variety of research focusing on cancer survivorship. With a focus on thematic topics in cancer survivorship, we describe how the CRN has contributed to research in cancer survivorship and the resources it offers for future collaborations. RESULTS: We identified the following areas of cancer survivorship research: surveillance for and predictors of recurrences, health care delivery and care coordination, health care utilization and costs, psychosocial outcomes, cancer communication and decision making, late effects of cancer and its treatment, use of and adherence to adjuvant therapies, and lifestyle and behavioral interventions following cancer treatment. CONCLUSIONS: With over a decade of experience using cancer data in community-based settings, the CRN investigators and their collaborators are poised to generate evidence in cancer survivorship research. IMPLICATIONS FOR CANCER SURVIVORS: Collaborative research within these settings can improve the quality of care for cancer survivors within and beyond integrated health care delivery systems.
Authors:
Larissa Nekhlyudov; Sarah M Greene; Jessica Chubak; Borsika Rabin; Leah Tuzzio; Sharon Rolnick; Terry S Field
Related Documents :
24969256 - Survivorship care plans.
23305796 - Molecular markers in pancreatic cancer diagnosis.
23750236 - Different effects of three polymorphisms in micrornas on cancer risk in asian populatio...
23099806 - The incidence of pancreatic cancer in brca1 and brca2 mutation carriers.
21761116 - Role of transforming growth factor-β1 -509 c/t promoter polymorphism in gastric cancer...
9951876 - Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated w...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-14
Journal Detail:
Title:  Journal of cancer survivorship : research and practice     Volume:  -     ISSN:  1932-2267     ISO Abbreviation:  J Cancer Surviv     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101307557     Medline TA:  J Cancer Surviv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Population MedicineHarvard Medical School/Harvard Pilgrim Health Care InstituteDepartment of MedicineHarvard Vanguard Medical Associates, 133 Brookline Avenue, 6th Floor, Boston, MA, 02215, USA, Larissa_Nekhlyudov@harvardpilgrim.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.
Next Document:  A re-evaluation of fifteen years of European risk assessment using effect models.